Immunity for Health: Vaccines & Immunotherapy

16–17 Oct 2024 | RodeBol Events

Thaer Kilani

Associate Director Business Development

LabConnect

Den Haag, Netherlands

1 profile visit

Helping Vaccine ClinOps deliver Biospecimen Data for Complex Vaccine Clinical Trials.

About me

My organisation

LabConnect

Social media

Interests

  • vaccine trials
  • Clinical development
  • clinical operations
  • central lab
  • biomarker development
  • biomarker operations
  • bioanalytical strategy
  • sample management
  • biospecimens
  • clinical trials

Additional questions

How would you categorise yourself?

Business DeveloperService provider

Organisation Type

Professional Services & ConsultingContract Research Organizations (CRO)Other

Areas of expertise

Supply chain management and logisticsData management, analytics and monitoringCell and Gene therapyClinical development and trialsImmuno-oncology

Therapeutic areas

Cardiovascular diseases Neurodegenerative diseases AllergiesInfectious diseases OncologyImmunologyAutoimmune disorders Rare diseases Respiratory diseases Other

1. I accept the General Terms & Conditions and Privacy Statement, available on flandersvaccine.be and agree that pictures can be taken at the event and be used for Flanders Vaccine communication purposes.

I agree

Marketplace (1)

  • Service

    What are the considerations for vaccine trial central lab testing?

    A central lab model for vaccine studies: custom kit build/resupply, global testing, real-time sample tracking, and data management.

    • Others
    • Others
    • Human health
    • Immunotherapy
    • Preventive vaccines
    • Therapeutic vaccines
    • Research & Development
    • Antimicrobial resistance
    • Global health (vaccines for LMIC)
    Author

    Thaer Kilani

    Associate Director Business Development at LabConnect

    Den Haag, Netherlands